Dr Anne Moore with microneedle patches on her hand Image Tomás Tyner
Researchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses of vaccine in pre-clinical testing.
The lead researcher, Dr Anne Moore, heads to Silicon Valley next week to meet venture capitalists and leading technology companies with a view to commercialising the research.
The microneedle-based patch also overcomes one of the main problems with this type of vaccine which relates to overcoming pre-existing immunity to the vaccine. The scientists combined two vaccine technologies to determine if immunity could be further enhanced and the research suggests that using a microneedle patch would overcome the need to make and use multiple different vaccine types to induce protective immunity to some of the world’s biggest killers. This could have significant consequences on the costs and logistics of vaccination.
The work was carried out by researchers in the School of Pharmacy, Dept. of Pharmacology and the Tyndall National Institute, UCC, led by Dr Anne Moore in collaboration with colleagues at the Jenner Institute, University of Oxford and was published byNature Publication Group in Scientific Reports and funded by Enterprise Ireland and Science Foundation Ireland. Dr Moore’s visit to Silicon Valley is being hosted by the Irish Technology Leadership Group (ITLG) as part of an SFI initiative for researchers to help them develop their entrepreneurial skills in the Get Started Venture Technology programme.
The skin patch has arrays of tiny silicon ‘microneedles’ that painlessly create temporary pores in the very outermost barrier layer of the skin, permitting the vaccine to flow into the skin, which is rich in cells of the immune system. The experimental vaccine was based on a live adenovirus. This virus is similar to those that can cause a common cold, but is engineered to be safer and to deliver a protein from the malaria-causing parasite, to the immune system.
The Latest on: Malaria vaccine
[google_news title=”” keyword=”Malaria vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Malaria vaccine
- Ask an expert: Is the threat of malaria increasing?on September 29, 2023 at 1:01 pm
Climate change, insecticide resistance, upticks in urban mosquitoes: Could malaria be getting worse? Our expert explains why investing in innovations that stop malaria is more important than ever.
- mRNA Vaccine Manufacturing Comes to Africaon September 26, 2023 at 10:44 pm
The COVID-19 pandemic highlighted a need for local production of vaccines. Now, German pharma company BioNTech has said it will start manufacturing vaccines in Africa.
- Eliminate malaria once and for all or it will come back stronger, UN warnedon September 22, 2023 at 9:02 pm
World faces ‘malaria emergency’ from resistance to insecticides, waning efficacy of drugs, funding shortfalls and climate change African leaders have warned that the world is facing the ...
- Stopping Malaria from Killing Children is a Matter of Urgency | Opinionon September 21, 2023 at 6:32 am
Nothing focuses the mind like visiting a ward where 24 infants with severe malaria are fighting for their lives. There is nothing like witnessing the silent desperation of a mother. No conversation ...
- Implementation of RTS,S/AS01 Malaria Vaccine — The Need for Further Evidenceon September 20, 2023 at 5:00 pm
In this trial, children 5 to 17 months of age and infants 6 to 12 weeks of age were randomly assigned to receive three doses of the malaria vaccine or a comparator vaccine, administered ...
- Malaria Vaccines market study identifies new markets and industries to target from 2023 to 2030 and its projected CAGR Value of 6.3%on September 13, 2023 at 3:47 am
The "Malaria Vaccines Market" study examines every facet of the market including product categories, geographic areas, and end-users. This report consists of 200 pages. The Malaria Vaccines market ...
- Malaria Vaccine: Why is it Taking so Long?on September 8, 2023 at 5:00 pm
Vaccines against malaria have been the object of constant endeavor by the scientific community and pharmaceutical industries for over three decades, with little success so far. Hopes for ...
- Vaccines alone won’t stop malariaon September 7, 2023 at 5:59 am
Malaria vaccines are welcome, but they won’t be enough to stop the disease, argues Rosebell Kagumire. US Army medical researchers administer malaria vaccines as part of World Malaria Day in Kenya in ...
- Kenya’s hard won gains against malaria threatened by surging temperatureson September 7, 2023 at 3:16 am
Now there are fears that the malaria is spreading to new communities in the country – and just at a time when the development of the world’s first mosquito vaccine is raising hopes the deadly ...
- Uganda to receive malaria vaccine in April 2024on September 5, 2023 at 10:04 am
Uganda is going to receive malaria vaccine in April 2024, the senior medical officer in-charge of chemo-prevention and malaria vaccine at the Malaria Control Division Ministry of Health ...
via Bing News
